Skip to content
2000
Volume 10, Issue 2
  • ISSN: 1573-4013
  • E-ISSN: 2212-3881

Abstract

Gaertn or Linn, colloquially known as the Indian gooseberry or amla, is an important medicinal plant in the Indian traditional system of medicine, the Ayurveda and is classified as a which when translated means cardiotonic drug. Numerous preclinical studies with laboratory animals have shown that amla does possess cardioprotective and anticoagulant effects and is useful in delaying/preventing/ reducing experimentally induced cardiotoxicity, atherosclerosis, myocardial infarction, hypertension and reducing ischemic-reperfusion injury. The pleiotropic effect of amla is believed to be due to the presence of various phytochemicals and studies have shown that the tannoids (emblicanin-A and –B), gallic acid, ellagic acid and corilagin also possess cardioprotective properties. Additionally, clinical studies have also shown that the regular intake of amla was effective in reducing the cholesterol levels and the effect to be similar to that of the conventionally used HMG CoA reductase inhibitor, simvastatin. Recent studies have also shown that amla improves endothelial function and reduced biomarkers of oxidative stress and systemic inflammation in patients with type 2 diabetes mellitus. This review for the first time summarizes the results related to these properties and also emphasizes the aspects that warrant future research to establish its activity and utility as a cardioprotective/cardiotonic therapeutic drug in humans.

© 2014 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnf/10.2174/1573401310666140322001132
2014-05-01
2025-09-27

  • From This Site

    /content/journals/cnf/10.2174/1573401310666140322001132
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. World Health Organization.WHO Disease and Injury Country Estimates.2009Geneva, Switzeradnd.
     [Google Scholar]
  2. World Health Organization.World Health Organization Statistical Information System (WHOSIS).2010Geneva, Switzerland.
     [Google Scholar]
  3. DwivediS. AggarwalA. Indigenous drugs in ischemic heart disease in patients with diabetes.J. Altern. Complement. Med.20091512151221
     [Google Scholar]
  4. GroverJ.K. YadavS. VatsV. Medicinal plants of India with antidiabetic potential.J. Ethnopharmacol.20028181100
     [Google Scholar]
  5. MukherjeeP.K. MaitiK. MukherjeeK. HoughtonP.J. Leads from Indian medicinal plants with hypoglycemic potentials.J. Ethnopharmacol.2006106128
     [Google Scholar]
  6. RaoP.T. OkamotoT. AkitaN. HayashiT. Kato-YasudaN. SuzukiK. Amla Emblica officinalis Gaertn.) extract inhibits lipopolysaccharide-induced procoagulant and pro-inflammatory factors in cultured vascular endothelial cells.Br. J. Nutr.2013716
     [Google Scholar]
  7. KrishnaveniM. MirunaliniS. Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder.J. Basic Clin. Physiol. Pharmacol.20102193105
     [Google Scholar]
  8. BaligaM.S. DsouzaJ.J. Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer.Eur. J. Cancer Prev.20112022520239
     [Google Scholar]
  9. KimH.J. YokozawatT. KimH.Y. TohdaC. RaoT.P. JunejaL.R. Influence of Amla (Emblica officinalis Gaertnl) on hypercholesterolemia and lipid peroxidation in cholesterol-fed rats.J. Nutr. Sci. Vitaminol.200551413418
     [Google Scholar]
  10. AroraD. RichaS. SharmaS. SutteeA. Phytochemical and microscopical investigations on Emblica officinalis Gaertn.Int. J. Pharmacog. Phytochem. Res.20124; 1-4.
     [Google Scholar]
  11. KhanK.H. Roles of Emblica officinalis in medicine – A review.Bot. Res. Int.20092218228
     [Google Scholar]
  12. KrishnaveniM. MirunaliniS. KarthishwaranK. DhamodharanG. Antidiabetic and anti-hyperlipidemic properties of Phyllanthis emblica Linn(Euphorbiaceae) on Streptozotocin induced diabetic rats.Pak. J. Nutr.201094351
     [Google Scholar]
  13. UsharaniP. FatimaN. MuralidharN. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study.Diabetes Metab. Syndr. Obes.20136275284
     [Google Scholar]
  14. MastanS.K. KumarK.E. BabuS.M. DasM.C. ChaitanyaG. Cardiotonic activity of aqueous extract of Emblica officinalis fruits.Asian J. Chem.20092145084514
     [Google Scholar]
  15. WattanapitayakulS.K. ChularojmontriL. HerunsaleeA. CharuchongkolwongseS. NiumsakulS. BauerJ.A. Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity.Basic Clin. Pharmacol. Toxicol.2005968087
     [Google Scholar]
  16. WangY.F. WangX.Y. RenZ. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.Antiviral Res.200984150158
     [Google Scholar]
  17. BonowR.O. MannD.L. ZipesD.P. LibbyP. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 2012; Single Volume, 9th edition, Saunders, 1600 John F. Kennedy Blvd, Ste. 1800, Philadelphia, PA 19103-2899, USA
  18. OjhaS. GolechhaM. KumariS. AryaD.S. Protective effect of Emblica officinalis (amla) on isoproterenol-induced cardiotoxicity in rats.Toxicol. Ind. Health2011 Oct 27
     [Google Scholar]
  19. Ramadoss. S, Kannan. K, Balamurugan. K, Jeganathan NS and Manavalan R. Cardioprotective effect of Cyathula prostrata Linn on isoproterenol induced myocardial infarction in rat.Int. J. Res. Pharma. Biomed. Sci.20123551555
     [Google Scholar]
  20. PrinceP.S. SathyaB. Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats.Eur. J. Pharmacol.2010635142148
     [Google Scholar]
  21. StanelyM.P. PriscillaH. DevikaP.T. Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in Wistar rats.Eur. J. Pharmacol.2009615139143
     [Google Scholar]
  22. PriscillaD.H. PrinceP.S. Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats.Chem. Biol. Interact.2009179118124
     [Google Scholar]
  23. KearneyP.M. WheltonM. ReynoldsK. MuntnerP. WheltonP.K. HeJ. Global burden of hypertension: analysis of worldwide data.Lancet2005365217223
     [Google Scholar]
  24. ThakurC.P. ThakurB. SinghS. SinhaP.K. SinhaS.K. The Ayurvedic medicines Haritaki, Amala and Bahira reduce cholesterol-induced atherosclerosis in rabbits.Int. J. Cardiol.198821167175
     [Google Scholar]
  25. GershB.J. SliwaK. MayosiB.M. YusufS. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.Eur. Heart J.201031642648
     [Google Scholar]
  26. BhatiaJ. TabassumF. SharmaA.K. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.Cardiovasc. Toxicol.201111272279
     [Google Scholar]
  27. BhattacharyaS.K. BhattacharyaA. SairamK. GhosalS. Effect of bioactive tannoid principles of Emblica officinalis on ischemia-reperfusion-induced oxidative stress in rat heart.Phytomedicine20029171174
     [Google Scholar]
  28. RajakS. BanerjeeS.K. SoodS. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats.Phytother. Res.2004185460
     [Google Scholar]
  29. ShawJ.E. SicreeR.A. ZimmetP.Z. Global estimates of the prevalence of diabetes for 2010 and 2030.Diabetes Res. Clin. Pract.201087414
     [Google Scholar]
  30. VoulgariC. PapadogiannisD. TentolourisN. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.Vasc. Health Risk Manag.20106883903
     [Google Scholar]
  31. AmosA.F. McCartyD.J. ZimmetP. The rising global burden of diabetes and its complications: estimates and projections to the year 2010.Diabet. Med.199714S1S85
     [Google Scholar]
  32. PatelS.S. GoyalR.K. Prevention of diabetes-induced myocardial dysfunction in rats using the juice of the Emblica officinalis fruit.Exp. Clin. Cardiol.2011168791
     [Google Scholar]
  33. GrundyS.M. DenkeM.A. Dietary influences on serum lipids and lipoproteins.J. Lipid Res.19903111491172
     [Google Scholar]
  34. MathurR. SharmaA. DixitV.P. VarmaM. Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits.J. Ethnopharmacol.1996506168
     [Google Scholar]
  35. AugustiK.T. ArathyS.L. AshaR. A comparative study on the beneficial effects of garlic (Allium sativum Linn), amla (Emblica officinalis Gaertn) and onion (Allium cepa Linn) on the hyperlipidemia induced by butter fat and beef fat in rats.Indian J. Exp. Biol.200139760766
     [Google Scholar]
  36. YokozawaT. KimH.Y. KimH.J. OkuboT. ChuD.C. JunejaL.R. Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process.Br. J. Nutr.20079711871195
     [Google Scholar]
  37. KimH.Y. OkuboT. JunejaL.R. YokozawaT. The protective role of amla (Emblica officinalis Gaertn) against fructose-induced metabolic syndrome in a rat model.Br. J. Nutr.2010103502512
     [Google Scholar]
  38. KoshyS.M. BobbyZ. HariharanA.P. GopalakrishnaS.M. Amla (Emblica officinalis) extract is effective in preventing high fructose diet-induced insulin resistance and atherogenic dyslipidemic profile in ovariectomized female albino rats.Menopause20121911461155
     [Google Scholar]
  39. AkhtarM.S. RamzanA. AliA. AhmadM. Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients.Int. J. Food Sci. Nutr.201162609616
     [Google Scholar]
  40. ChenT.S. LiouS.Y. WuH.C. Efficacy of epigallocatechin-3-gallate and Amla (Emblica officinalis) extract for the treatment of diabetic-uremic patients.J. Med. Food201114718723
     [Google Scholar]
  41. GopaB. BhattJ. HemavathiK.G. A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin.Indian J. Pharmacol.201244238242
     [Google Scholar]
  42. AnilaL. VijayalakshmiN.R. Beneficial effects of flavonoids from Sesamum indicum. Emblica officinalis and Momordica charantia.Phytother. Res.200014592595
     [Google Scholar]
  43. AnilaL. VijayalakshmiN.R. Flavonoids from Emblica officinalis and mangifera indica-effectiveness for dyslipidemia.J. Ethnopharmacol.2002798187
     [Google Scholar]
  44. VessalM. HemmatiM. VaseiM. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats.Comp. Biochem. Physiol. Toxicol. Pharmacol.2003135C357364
     [Google Scholar]
  45. JuzwiakS. WicickiJ. MokrzyckiK. Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits.Pharmacol. Rep.200557604609
     [Google Scholar]
  46. DuanW. YuY. ZhangL. Antiatherogenic effects of Phyllanthus emblica associated with corilagin and its analogue.Yakugaku Zasshi2005125587591
     [Google Scholar]
  47. MuraseT. KumeN. HaseT. Gallates inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of leukocyte adhesion molecules in vascular endothelial cells.Arterioscler. Thromb. Vasc. Biol.19991914121420
     [Google Scholar]
  48. AppeldoornC.C. BonnefoyA. LuttersB.C. Gallic acid antagonizes P-selectin-mediated platelet-leukocyte interactions: implications for the French paradox.Circulation2005111106112
     [Google Scholar]
  49. YuY.M. WangZ.H. LiuC.H. ChenC.S. Ellagic acid inhibits IL-1beta-induced cell adhesion molecule expression in human umbilical vein endothelial cells.Br. J. Nutr.200797692698
     [Google Scholar]
  50. YuY.M. ChangW.C. WuC.H. ChiangS.Y. Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid.J. Nutr. Biochem.200516675681
     [Google Scholar]
  51. ChangW.C. YuY.M. ChiangS.Y. TsengC.Y. Ellagic acid suppresses oxidised low-density lipoprotein-induced aortic smooth muscle cell proliferation: studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression.Br. J. Nutr.200899709714
     [Google Scholar]
  52. LeeW.J. OuH.C. HsuW.C. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.J. Vasc. Surg.20105212901300
     [Google Scholar]
  53. OuH.C. LeeW.J. LeeS.D. Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway.Toxicol. Appl. Pharmacol.2010248134143
     [Google Scholar]
  54. ParkS.H. KimJ.L. LeeE.S. Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages.J. Nutr.201114119311937
     [Google Scholar]
  55. PandeyG. PandeyS.P. Phytochemical and toxicity study of Emblica officinalis.Int Res J Pharma201122702
     [Google Scholar]
/content/journals/cnf/10.2174/1573401310666140322001132
Loading
Cardioprotective Effects of Indian Gooseberry (Emblica officinalis Gaertn) and its Phytochemicals: A Review
Curr. Nutr. Food Sci. 10, 141 (2014); https://doi.org/10.2174/1573401310666140322001132
/content/journals/cnf/10.2174/1573401310666140322001132
/content/journals/cnf/10.2174/1573401310666140322001132
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): amla; atherosclerosis; cardiotoxicity; corilagin; ellagic acid; Emblica officinalis; gallic acid; hypertension; Indian gooseberry; ischemic-reperfusion injury; myocardial infarction; Phyllanthus emblica

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test